Janney Montgomery Scott LLC Sells 7,444 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Janney Montgomery Scott LLC reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 12.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 52,032 shares of the medical equipment provider's stock after selling 7,444 shares during the quarter. Janney Montgomery Scott LLC's holdings in Intuitive Surgical were worth $27,159,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of ISRG. LVW Advisors LLC lifted its position in Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after buying an additional 19 shares during the last quarter. Hazlett Burt & Watson Inc. lifted its holdings in shares of Intuitive Surgical by 5.8% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider's stock worth $177,000 after acquiring an additional 20 shares during the last quarter. Mitchell Mcleod Pugh & Williams Inc. boosted its stake in shares of Intuitive Surgical by 4.1% in the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider's stock valued at $247,000 after purchasing an additional 20 shares in the last quarter. Fragasso Financial Advisors Inc grew its holdings in shares of Intuitive Surgical by 3.0% during the 4th quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider's stock valued at $359,000 after purchasing an additional 20 shares during the last quarter. Finally, Ullmann Wealth Partners Group LLC raised its position in Intuitive Surgical by 1.6% in the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider's stock worth $653,000 after purchasing an additional 21 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In related news, CEO Gary S. Guthart sold 18,151 shares of the company's stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares of the company's stock, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company's stock, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 42,475 shares of company stock valued at $22,070,807 in the last ninety days. 0.90% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on ISRG shares. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research note on Friday, October 18th. Leerink Partners increased their price objective on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Truist Financial lifted their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a "buy" rating in a research note on Friday. Stifel Nicolaus increased their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research report on Thursday, December 5th. Finally, Morgan Stanley upgraded shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and boosted their price objective for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus target price of $583.83.

Intuitive Surgical Price Performance

NASDAQ:ISRG traded down $24.61 during mid-day trading on Friday, hitting $584.05. 4,350,539 shares of the company's stock were exchanged, compared to its average volume of 1,342,626. The company has a market cap of $208.03 billion, a PE ratio of 93.90, a P/E/G ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The business has a fifty day moving average price of $547.16 and a 200 day moving average price of $504.35.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.